Monash IVF Group Crecimiento futuro

Future controles de criterios 0/6

Se prevé que los beneficios de Monash IVF Group disminuyan en un 0.8% al año, mientras que se espera que sus ingresos anuales crezcan en un 1.4% al año. Se prevé que el BPA crezca en un 0.3% por año. Se espera que la rentabilidad financiera sea de 9.1% en 3 años.

Información clave

-0.8%

Tasa de crecimiento de los beneficios

0.32%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	18.8%
Tasa de crecimiento de los ingresos	1.4%
Rentabilidad financiera futura	9.11%
Cobertura de analistas	Good
Última actualización	24 Nov 2025

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Subdued Growth No Barrier To Monash IVF Group Limited's (ASX:MVF) Price

Nov 13

Is Monash IVF Group (ASX:MVF) A Risky Investment?

Aug 22

Benign Growth For Monash IVF Group Limited (ASX:MVF) Underpins Stock's 26% Plummet

Jun 17

Monash IVF Group (ASX:MVF) Seems To Use Debt Quite Sensibly

May 20

Monash IVF Group Limited's (ASX:MVF) Popularity With Investors Under Threat As Stock Sinks 26%

Apr 29

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Nov 04

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

May 14

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Jun 06

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

May 25

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

May 13

Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Mar 14

Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Mar 04

Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Feb 26

Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

Feb 15

A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

Feb 03

We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Jan 22

Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Jan 10

Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

Dec 28

What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Dec 17

Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Dec 06

Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

Nov 24

Previsiones de crecimiento de beneficios e ingresos

ASX:MVF - Estimaciones futuras de los analistas y datos financieros pasados (AUD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2028	281	23	29	52	7
6/30/2027	270	21	26	48	7
6/30/2026	261	18	27	42	7
6/30/2025	272	25	-2	13	N/A
3/31/2025	271	11	5	21	N/A
12/31/2024	270	-2	12	29	N/A
9/30/2024	263	-4	22	41	N/A
6/30/2024	255	-7	31	53	N/A
3/31/2024	246	9	27	51	N/A
12/31/2023	236	24	22	49	N/A
9/30/2023	225	23	17	44	N/A
6/30/2023	214	22	11	39	N/A
3/31/2023	204	19	11	36	N/A
12/31/2022	195	17	11	33	N/A
9/30/2022	193	18	16	32	N/A
6/30/2022	192	18	20	32	N/A
3/31/2022	193	21	25	35	N/A
12/31/2021	194	23	30	38	N/A
9/30/2021	189	24	32	41	N/A
6/30/2021	184	25	34	44	N/A
3/31/2021	171	22	33	43	N/A
12/31/2020	159	18	31	41	N/A
9/30/2020	152	15	27	36	N/A
6/30/2020	145	12	24	31	N/A
3/31/2020	149	15	22	30	N/A
12/31/2019	152	18	20	28	N/A
9/30/2019	152	19	23	31	N/A
6/30/2019	152	20	27	33	N/A
3/31/2019	151	19	N/A	31	N/A
12/31/2018	151	19	N/A	29	N/A
9/30/2018	151	20	N/A	28	N/A
6/30/2018	151	21	N/A	26	N/A
3/31/2018	152	24	N/A	N/A	N/A
12/31/2017	153	26	N/A	29	N/A
9/30/2017	154	28	N/A	28	N/A
6/30/2017	155	30	N/A	26	N/A
3/31/2017	156	30	N/A	N/A	N/A
12/31/2016	156	30	N/A	34	N/A
9/30/2016	156	29	N/A	39	N/A
6/30/2016	157	29	N/A	44	N/A
3/31/2016	150	27	N/A	41	N/A
12/31/2015	144	24	N/A	38	N/A
9/30/2015	134	23	N/A	37	N/A
6/30/2015	125	21	N/A	36	N/A
3/31/2015	121	15	N/A	37	N/A
12/31/2014	117	8	N/A	38	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que los beneficios de MVF disminuyan en los próximos 3 años (-0.8% al año).

Beneficios vs. Mercado: Se prevé que los beneficios de MVF disminuyan en los próximos 3 años (-0.8% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de MVF disminuyan en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (1.4% al año) de MVF crezcan más despacio que el mercado de Australian (5.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 1.4% al año) de MVF crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de MVF sea baja dentro de 3 años (9.1%).

Descubre empresas en crecimiento

Análisis de la empresa y estado de los datos financieros

Datos	Última actualización (huso horario UTC)
Análisis de la empresa	2025/11/25 21:08
Precio de las acciones al final del día	2025/11/25 00:00
Beneficios	2025/06/30
Ingresos anuales	2025/06/30

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

Paquete	Datos	Marco temporal	Ejemplo Fuente EE.UU. ^*
Finanzas de la empresa	10 años	Cuenta de resultados Estado de tesorería Balance	Formulario SEC 10-K Formulario SEC 10-Q
Estimaciones del consenso de analistas	+3 años	Previsiones financieras Objetivos de precios de los analistas	Informes de análisis Blue Matrix
Precios de mercado	30 años	Precios de las acciones Dividendos, escisiones y acciones	Datos de mercado ICE Formulario S-1 de la SEC
Propiedad	10 años	Accionistas principales Información privilegiada	Formulario SEC 4 Formulario SEC 13D
Gestión	10 años	Equipo directivo Consejo de Administración	Formulario SEC 10-K Formulario SEC DEF 14A
Principales avances	10 años	Anuncios de empresas	Formulario SEC 8-K

^* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Monash IVF Group Limited está cubierta por 12 analistas. 7 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

Analista	Institución
Bradley Watson	Bell Potter
Martyn Jacobs	Bell Potter
Tara Speranza	Bell Potter

Monash IVF Group Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased by 12% to AU$0.94

Price target decreased by 8.3% to AU$1.01

Price target decreased by 11% to AU$1.16

Price target decreased by 8.1% to AU$1.40

Price target increased by 7.3% to AU$1.42

Consensus forecasts updated

Recent updates

WHSP Holdings Limited (ASX:SOL) and Genesis Capital cancelled the acquisition of remaining 80.4% stake in Monash IVF Group Limited (ASX:MVF) for approximately AUD 250 million.

New major risk - Revenue and earnings growth

Subdued Growth No Barrier To Monash IVF Group Limited's (ASX:MVF) Price

Monash IVF Group Limited, Annual General Meeting, Nov 20, 2025

New major risk - Revenue and earnings growth

Price target decreased by 12% to AU$0.94

New major risk - Revenue and earnings growth

Is Monash IVF Group (ASX:MVF) A Risky Investment?

Price target decreased by 8.3% to AU$1.01

Full year 2025 earnings released: EPS: AU$0.064 (vs AU$0.017 loss in FY 2024)

New major risk - Revenue and earnings growth

Benign Growth For Monash IVF Group Limited (ASX:MVF) Underpins Stock's 26% Plummet

Monash IVF Group Limited Announces CEO Changes

New minor risk - Share price stability

Price target decreased by 11% to AU$1.16

Monash IVF Group (ASX:MVF) Seems To Use Debt Quite Sensibly

Monash IVF Group Limited's (ASX:MVF) Popularity With Investors Under Threat As Stock Sinks 26%

Price target decreased by 8.1% to AU$1.40

Monash IVF Group (ASX:MVF) Is Increasing Its Dividend To A$0.026

First half 2025 earnings: EPS and revenues exceed analyst expectations

First half dividend increased to AU$0.026

Monash IVF Group Limited Declares Fully Franked Interim Dividend for the First Half ended 31 December 2024, Payable on 11 April 2025

Monash IVF Group Limited to Report Fiscal Year 2025 Results on Aug 22, 2025

Smallcap takeover in niche industry

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought AU$93k worth of stock

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings: EPS misses analyst expectations

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Price target increased by 7.3% to AU$1.42

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group (ASX:MVF) Will Pay A Dividend Of A$0.022

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Here's What's Concerning About Monash IVF Group's (ASX:MVF) Returns On Capital

Insufficient new directors

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Consensus forecasts updated

Upcoming dividend of AU$0.022 per share

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2022 earnings: EPS misses analyst expectations

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Consensus EPS estimates fall by 16%

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

Consensus EPS estimates fall by 10%

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Price target increased to AU$1.08